Difficulty: Medium
Average Score: 91%
Practice
A 3-year-old girl presents to the emergency department with a history of recurrent UTIs with costovertebral angle tenderness, high fever, and dysuria. A urine culture grows gram-negative lactose-fermenting rods. The physician suspects E. coli pyelonephritis. Ciprofloxacin is highly effective against E. coli in vitro, but the physician chooses not to use it in this case. Why would she choose not to prescribe ciprofloxacin?
Correct answer
B
Rationale
The correct answer is B) Ciprofloxacin is contraindicated in patients younger than 18 years old. This is because ciprofloxacin belongs to a class of antibiotics called fluoroquinolones, which are associated with potential serious side effects like tendon rupture and joint problems in pediatric patients. The use of ciprofloxacin in children under 18 years old is generally restricted to specific situations where no other suitable alternative exists due to these safety concerns.
Option A is incorrect because ciprofloxacin is actually bactericidal, meaning it kills bacteria rather than just inhibiting their growth (bacteriostatic).
Option C is incorrect as ciprofloxacin is effective against E. coli both in vitro (in laboratory settings) and in vivo (in the body), but its use is limited in pediatric populations due to safety reasons.
Option D is incorrect because although ciprofloxacin can have side effects like any medication, nephrotoxicity (toxic to the kidneys) is not a primary concern associated with this drug.
Educationally, it is crucial for healthcare providers to be aware of age-specific contraindications and safety considerations when prescribing medications, especially antibiotics, to pediatric patients. Understanding the rationale behind drug choices based on patient age, safety profiles, and efficacy helps in providing optimal care while minimizing potential risks.
Option A is incorrect because ciprofloxacin is actually bactericidal, meaning it kills bacteria rather than just inhibiting their growth (bacteriostatic).
Option C is incorrect as ciprofloxacin is effective against E. coli both in vitro (in laboratory settings) and in vivo (in the body), but its use is limited in pediatric populations due to safety reasons.
Option D is incorrect because although ciprofloxacin can have side effects like any medication, nephrotoxicity (toxic to the kidneys) is not a primary concern associated with this drug.
Educationally, it is crucial for healthcare providers to be aware of age-specific contraindications and safety considerations when prescribing medications, especially antibiotics, to pediatric patients. Understanding the rationale behind drug choices based on patient age, safety profiles, and efficacy helps in providing optimal care while minimizing potential risks.